PASSAGE BIO INC. - COMMON STOCK
0.6294
01-11月-24 15:58:16
15 分の遅延
株式
+0.0144
+2.34%
本日の幅
0.6100 - 0.6500
ISIN
N/A
ソース
NASDAQ
-
Passage Bio Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
17 9 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Passage Bio Announces Maxine Gowen, Ph.D., as Chairwoman of the Board of Directors
07 9 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference
02 9 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
27 8 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Passage Bio Mourns the Sudden Passing of Chairman of the Board Tadataka Yamada, M.D.
04 8 2021 21:00:00 提供 Nasdaq GlobeNewswire
-
Passage Bio to Present at 12th Annual Wedbush PacGrow Healthcare Conference
04 8 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio to Report Second Quarter 2021 Financial Results on August 5, 2021
29 7 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
21 7 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio Announces Key Executive Appointments
19 7 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Derrell D. Porter, M.D., Elected to Board of Directors of Passage Bio
01 6 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming June Investor Conferences
26 5 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio Announces Pre-Clinical Data Presentation at Annual ASGCT Meeting
11 5 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Passage Bio to Host Virtual R&D Event on May 17
10 5 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Passage Bio Reports First Quarter 2021 Financial Results and Recent Business Highlights
05 5 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
03 5 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Passage Bio to Report First Quarter 2021 Financial Results on May 5, 2021
29 4 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
05 4 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
01 4 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming April Investor Conferences
25 3 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
22 3 2021 07:00:00 提供 Nasdaq GlobeNewswire